Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 44

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Phenylboronic Acid Based Mucoadhesive Polymeric Micelles for Reduction in Intra-Ocular Pressure (IOP) during Glaucoma

Aftab Taiyab; Jennifer Tian; Lina Liu; Frances Lasowski; Ben B Muirhead; Talena Rambarran; Monica Akula; Paula Deschamps; Terete Borras; Trevor Williams; Judith A West-Mays; Heather Sheardown

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1359. doi:

ARVO Annual Meeting Abstract June 2020

Role of AP-2β Transcription Factor in Early Postnatal Development of the Trabecular Meshwork

Monica Akula; Aftab Taiyab; Paula Deschamps; Trevor Williams; Terete Borras; Judith A West-Mays

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2327. doi:

ARVO Annual Meeting Abstract June 2020

Mechanisms of Formation of Exfoliation Material in Human Surgical Specimens

Terete Borras; David Fleischman; Robert Ritch; Carl Parson II

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4264. doi:

ARVO Annual Meeting Abstract July 2019

Matrix Gla Functions as a Keeper of Physiological Intraocular Pressure (IOP) in the Mouse Eye

Terete Borras; Priyadarsini Asokan; Millena Sivakumar; Michael R. Falvo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5209. doi:

ARVO Annual Meeting Abstract July 2018

IDENTIFYING PSEUDOEXFOLIATION GLAUCOMA MECHANISMS BY OVERPRODUCING WILD-TYPE AND N-TERMINUS-DELETED LOXL1 IN VITRO AND IN VIVO

Terete Borras; Renekia Elliott; Priyadarsini Asokan; Laura Rodriguez Estevez

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3029. doi:

ARVO Annual Meeting Abstract June 2017

A naturally fluorescent marker mouse for studying angiogenesis and glaucoma in vivo

Terete Borras; Priyadarsini Asokan; Rajendra Mitra; Zongchao Han

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4072. doi:

ARVO Annual Meeting Abstract June 2017

Generation of a transient (non-germline transmission) Mgp conditional - Knockout (c-KO) in the trabecular meshwork of living mice

Priyadarsini Asokan; Laura Rodriguez Estevez; Terete Borras

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3470. doi:

ARVO Annual Meeting Abstract June 2017

Different transduction efficiencies between single- and double-stranded Adeno-associated viruses (ssAAV & dsAAV) in the human trabecular meshwork extend across seven serotypes

Laura Rodriguez Estevez; Priyadarsini Asokan; Terete Borras

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3496. doi:

ARVO Annual Meeting Abstract September 2016

Intracameral Delivery of Gene Therapy Vector scAAV2.MMP1 Results in Negligible to None Systemic Presence of Viral Genomes in a Large Animal Model.

Renekia Elliott; Matthew Smith; LaKisha Buie; Terete Borras

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4694. doi:

ARVO Annual Meeting Abstract September 2016

Generation of a viable, fertile Matrix-Gla ( Mgp) -floxed mouse by CRISPR/CAS9 technology. Relevance for the creation of stiffness mouse models of glaucoma

Terete Borras; Kumar Pandya; Dale Cowley; Renekia Elliott

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3573. doi:

ARVO Annual Meeting Abstract June 2015

Matrix GLA (MGP) as an anti-stiffness candidate gene in the peripapillary sclera (ppSC) of the mouse

Terete Borras; Matthew H Smith; LaKisha Buie; MdZahid Karim

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4823. doi:

ARVO Annual Meeting Abstract June 2015

Ocular transduction following suprachoroidal space AAV vector administration in small and large animal models

Brian C Gilger; Terete Borras; Matthew Hirsch

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):259. doi:

ARVO Annual Meeting Abstract April 2014

Validation of Gene Delivery in Sheep Ocular Models Towards a Translation Strategy for Optimization of Human Eye Gene Therapy

Jacklyn H Salmon; Matthew Hirsch; Terete Borras; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3338. doi:

ARVO Annual Meeting Abstract April 2014

Increasing the Efficiency of Gene Therapy in Glaucoma by Selecting an Optimal scAAV serotype

Renekia Elliott; Brandon Lane; LaKisha Buie; Terete Borras

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5649. doi:

ARVO Annual Meeting Abstract April 2014

Generation of a Viable Matrix GLA Knock-In-Cre (MGP.KI.Cre) Mouse Reveals MGP Eye Expression Uniquely Targeted to the Trabecular Meshwork and Sclera Region Supporting the Optic Nerve Head

Matthew Halton Smith; LaKisha Buie; Terete Borras

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5665. doi:

ARVO Annual Meeting Abstract April 2014

Transgene Targeting of the Iris Pigment Epithelium (IPE) to Study and Potentially Treat Pseudoexfoliation Glaucoma

Terete Borras; Renekia Elliott; LaKisha Buie; Matthew Halton Smith; Matthew Hirsch; Brandon Lane

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5667. doi:

ARVO Annual Meeting Abstract April 2014

New Advances on the Gene Therapy Treatment of Steroid-induced Elevated IOP in Sheep

LaKisha Buie; Renekia Elliott; Brandon Lane; Matthew Halton Smith; Scott David Lawrence; Terete Borras

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5988. doi:

ARVO Annual Meeting Abstract June 2013

Effect of Tissue Plasminogen Activator on Outflow Facility of Steroid Injected Mouse Eyes

Shaily Shah; Sandeep Kumar; Terete Borras; Matthew Smith; John Danias

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):788. doi:

ARVO Annual Meeting Abstract March 2012

Anterior Chamber Delivery of Dominant-negative RhoA by an scAAV Vector Prevents Nocturnal IOP Elevation in Living Rats

LaKisha K. Buie; Juan Carabana; M. Grazia Spiga; Teresa Borras

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2486. doi:

ARVO Annual Meeting Abstract March 2012

Statins and Dominant-negative RhoA Inhibit Dexamethasone-induced Calcification in Human Trabecular Meshwork Cells

Juan Carabana; Wei Xue; Teresa Borras

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3247. doi:

1 2 3

Next 20 Results »

Advertisement